WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a global clinical research organization in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced today that it will issue its financial results for the first quarter of 2008 on Wednesday, May 14, 2008 after the close of the stock market, with an accompanying conference call on Thursday, May 15, 2008 at 11:00 A.M. ET.
